Abstract: Slide Presentations |


Ronald Oudiz, MD*; Anatoly Langer, MD; Alina Dragomir, MD; Amparo Casanova, MD, PhD; Mary Tan, BSc; Vallerie McLaughlin, MD; Richard Channick, MD; Victor Tapson, MD; Philip Clements, MD, MPH; Lewis Rubin, MD
Author and Funding Information

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA


Chest. 2007;132(4_MeetingAbstracts):474. doi:10.1378/chest.132.4_MeetingAbstracts.474
Text Size: A A A
Published online


PURPOSE: Implementation of the 2004 ACCP Recommendations for the Diagnosis and Differential Assessment of Pulmonary Arterial Hypertension (PAH) was measured as part of a quality enhancement research initiative (QuERI) in 517 patients with PAH among 52 US specialist physicians.

METHODS: Physicians were asked to enroll PAH patients (known or newly diagnosed) and provide data on recommended diagnostic tests.

RESULTS: (Median, 25th and 75th percentile): Patients enrolled were 55 years old (44, 66), 77% female, with a BMI of 27.5 kg/m2 (23, 33), BP was 118/70 mmHg (104,130/61,78), and heart rate was 80 bpm (72,92). Most were functional class II or greater (91%) and 40% were using supplemental oxygen. PAH was reported as idiopathic in 37%, familial in 3%,and was associated with conditions in 50% as follows: connective tissue disorders (CTD) in 28%, drug exposure in 9%, congenital systemic-to-pulmonary shunt in 7%, portal hypertension in 4%, HIV in 3% and associated with significant venous or capillary involvement in <1%; the rest having been classified as “other”. WHO class was available in 471 patients: 42 were class I (9%), 182 class II (39%), 222 class III (47%), and 25 class IV (5%).The frequency of recommended diagnostic tests was: chest x-ray: 82%, ECG: 72%, echocardiogram: 89%, right heart catheterization (RHC): 77%, pulmonary function testing: 77%, and V/Q scanning in only 52%. CTD screen: 53%, HIV: 36%, CBC: 89%, liver function: 93%. All three tests: CXR, ECG, and echocardiogram were performed in 344 out of 517 (67%) patients.

CONCLUSION: Physicians treating PAH report multiple etiologies requiring a comprehensive and multi-pronged approach to the diagnostic evaluation. This preliminary assessment suggests that certain essential diagnostic tests maybe underutilized. ACCP guidelines recommend V/Q scanning to exclude correctable causes of PAH. ACCP guidelines also recommend HIV testing in all patients evaluated for PAH. These guidelines are not universally followed based on this review.

CLINICAL IMPLICATIONS: Stricter adherence to guidelines may result in more optimal management of these high-risk patients.

DISCLOSURE: Ronald Oudiz, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, October 23, 2007

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543